Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?

Recruiting now

Conditions studied: Long COVID Syndrome

In brief

Millions have developed Long COVID (LC), and recent findings show an association between taurine deficiency (an amino acid) and symptoms in LC. Cost-effective and accessible interventions are needed to improve welfare and reduce healthcare costs. We will investigate the efficacy of 12-weeks of taurine supplementation (self-administered), on vascular function and the cardio/cerebrovascular responses to upright posture. We will measure resting vascular function with an EndoPAT device, resting heart rate variability, and the blood pressure, heart rate, and brain blood flow responses to 5 minutes of head-up tilt before and after weeks of taurine supplementation in LC. We hypothesize that the 12 weeks of supplementation will improve both resting vascular function and the responses to upright tilt. In turn, we hypothesize that symptoms will also improve (as measured by questionnaires).

Key facts

Study ID

NCT07312409

Run by

York University

People needed

30

Starts

2026-06-01

Expected to finish

2027-12-31

Last updated by the study team

2026-06-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants will have had symptoms of Long COVID post-infection for at least 3 months

You may not qualify if…

• Inability to undergo tilt table testing for 5 minutes
• Inability to transport selves to York University from their homes
• Inability to speak English, or provide a translator
• Blood clotting disorders

Where it is running

• York University — Toronto, Ontario, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.